Results 191 to 200 of about 118,712 (218)

HIV-1 Reverse Transcriptase Structure

2004
Kalyan Das, Stefan G. Sarafianos, Eddy Arnold, Stephen H. Hughes   +3 more
openaire   +1 more source

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

Lancet, The, 2008
Wafaa El-Sadr, Francois Dabis, Stéphane De Wit   +2 more
exaly  

HIV-1 reverse transcriptase inhibitors

2014
Krawczyk, Sören, Hilgeroth , Andreas
openaire   +1 more source

Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial

Lancet, The, 2007
Benjamin H Chi, Jeffrey S A Stringer
exaly  

HIV Nucleoside Reverse Transcriptase Inhibitors

2007
openaire   +1 more source

HIV-1 reverse transcriptase inhibitors

Drug Discovery Today, 1996
openaire   +1 more source

Molecular Modelling of HIV-1 Reverse Transcriptase Inhibitors

AIDS Research and Human Retroviruses, 1991
M. JAMES, C. CRABBE, SHAUN S. FALKINGBRIDGE   +2 more
openaire   +2 more sources

Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial

Lancet, The, 2011
Bonaventura Clotet, Kiat Ruxrungtham
exaly  

A Short-Term Clinical Evaluation of L-697,661, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase

New England Journal of Medicine, 1993
Michael S Saag, George M Shaw
exaly  

Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance

Science, 1998
Gregory L Verdine
exaly